论文信息 - Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis.

Decrease of the central type benzodiazepine receptor in cortical tubers in a patient with tuberous sclerosis.

An 18-year-old man with tuberous sclerosis was studied with I-123 lomazenil SPECT and the findings were compared with those of MRI. In all cortical tubers detected with MRI, 1-123 iomazenil binding 180-191 minutes after intravenous administration was decreased significantly. This result indicates that the binding potential of 1-123 lomazenil is decreased in cortical tubers.

[1] Y. Yonekura,et al. Simple quantification of benzodiazepine receptor binding and ligand transport using iodine-123-iomazenil and two SPECT scans. , 1995, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[2] M. Oshima,et al. Early detection of tuberous sclerosis by I-123 IMP SPECT in a neonate. , 1994, Clinical nuclear medicine.

[3] Y. Yonekura,et al. Regional cerebral blood flow in relation to MRI and EEG findings in tuberous sclerosis , 1991, Brain and Development.

[4] D. F. Preston,et al. Tc‐99m HMPAO SPECT Imaging of the Central Nervous System in Tuberous Sclerosis , 1991, Clinical nuclear medicine.

[5] H. W. Ilsen,et al. Hypometabolic Cortical Lesions in Tuberous Sclerosis with Epilepsy: Demonstration by Positron Emission Tomography , 1983, Journal of computer assisted tomography.